Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Molina, Luis
PRGN3006-001, NCT03927261: PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS	Active, not recruiting	1	88	US	PRGN-3006 T Cells	Precigen, Inc	Acute Myeloid Leukemia, Myelodysplastic Syndromes	08/24	08/25
NCT06170606: POLARx Post Approval Study (POLARx PAS)	Recruiting	N/A	200	US	Boston Scientific Cardiac Cryoablation System	Boston Scientific Corporation	Paroxysmal Atrial Fibrillation	05/26	05/29